Our Impact
Since we began in 2001, m2m has…
Created over 11,000 jobs for women living with HIV.
Reached more than 11M women and children under two in sub-Saharan Africa.
We undertake in-depth programme reviews every year.
We also release regular quarterly reports with our latest reach and impact.
In 2019, m2m…
Improved the health of women, children, and adolescents
Women
99%
of women we served who are living with HIV accessed treatment, substantially higher than an 85% benchmark in Eastern and Southern Africa. [2]
0.08%
of pregnant or breastfeeding women who were HIV-negative when enrolled into our programme contracted HIV in 2019—45 times lower than a 2020 rate across sub-Saharan Africa of 3.6%. [3]
98%
of our clients living with HIV were adherent to their treatment more than 95% of the time—surpassing World Health Organization goals (95% of individuals with 80% adherence).
90%
of m2m clients living with HIV who started antiretroviral therapy for the first time were still on treatment after a year— compared to 72% in Eastern and Southern Africa. [4]
2.^ UNAIDS 2019: Eastern and Southern Africa
3.^https://journals.lww.com/aidsonline/Abstract/2020/04010/Incident_HIV_among_pregnant_and_breast_feeding.12.aspx
4.^ UNAIDS 2019: Eastern and Southern Africa
Children
91%
of children we served who are living with HIV (aged 0-9) accessed treatment—compared to a benchmark of 76%.[5]
94%
of our early childhood development clients (aged 0-3) achieved all their developmental milestones at one year of age.
5.^ UNAIDS 2019 (Note: Among the benchmarks for children in the countries included in this analysis—Kenya, Lesotho, Malawi, Zambia—Zambia had the highest rate of 76%.)
Adolescents
182,431
adolescents (aged 10-19) were enrolled in our programme in 2019 —a 27% rise over the previous year.
96%
of our adolescent clients (aged 10-19) living with HIV were initiated on treatment—compared to a benchmark of 56% in UNAIDS 35 Fast-Track countries.[6]
